Skip Navigation

SL-401 in Patients with Advanced, High-Risk Myeloproliferative Neoplasms MPN

Brief Summary

Type:
Myelofibrosis

Study Type:
Treatment

Phase:
I/II

ClinicalTrials.gov Identifier:
NCT02268253

Study #:
STUDY00140410

Start Date:
Apr 13, 2017

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT02268253

View Complete Trial Details & Eligibility at ClinicalTrials.gov